The latest VC funding deals include announcements on Blue Arbor Technologies, Dren Bio, GoodMood Holdings, and others.
Blue Arbor Technologies Raises $10.5 Million Series A for Advanced Robotic Prosthetic Control
Michigan-based medical robotics startup Blue Arbor Technologies announced a $10.5 million Series A on October 28, led by German prosthetics manufacturer Ottobock. The company develops the RESTORE Neuromuscular Interface System, designed to help people with limb loss control robotic prostheses through signals from their peripheral nervous system. RESTORE aims to support independent movement of prosthetic fingers, wrists and elbows. Blue Arbor reports completing two human implantations, including a procedure at the Medical University of Vienna. Funding will support feasibility studies, preparation for US clinical trials and development of an implantable sensing system. The technology has received FDA Breakthrough Device Designation but remains under clinical development.
Dren Bio Raises $350 Million to Advance Cancer Drug Development and Commercialisation
California-based biotechnology company Dren Bio announced the closing of an oversubscribed $350 million private financing...